Quantbot Technologies LP Boosts Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Quantbot Technologies LP lifted its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 34.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 107,418 shares of the company's stock after acquiring an additional 27,732 shares during the quarter. Quantbot Technologies LP's holdings in Ryan Specialty were worth $7,131,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently modified their holdings of RYAN. Signaturefd LLC increased its stake in shares of Ryan Specialty by 12.3% in the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company's stock worth $89,000 after acquiring an additional 148 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Ryan Specialty by 5.2% during the third quarter. UMB Bank n.a. now owns 5,224 shares of the company's stock valued at $347,000 after purchasing an additional 256 shares in the last quarter. Loomis Sayles & Co. L P lifted its holdings in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after purchasing an additional 286 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Finally, Hollencrest Capital Management purchased a new stake in shares of Ryan Specialty in the 3rd quarter worth approximately $25,000. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Up 0.7 %

Shares of NYSE:RYAN traded up $0.51 during trading on Tuesday, reaching $75.10. The company's stock had a trading volume of 1,090,854 shares, compared to its average volume of 871,530. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.50. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm's 50 day simple moving average is $69.27 and its two-hundred day simple moving average is $62.80. The stock has a market capitalization of $19.66 billion, a PE ratio of 97.49, a price-to-earnings-growth ratio of 1.67 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.41. The company had revenue of $604.69 million during the quarter, compared to analysts' expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty's revenue was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 EPS. On average, research analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty's dividend payout ratio is currently 57.14%.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total value of $347,923.75. Following the completion of the sale, the director now directly owns 2,685 shares in the company, valued at approximately $173,800.05. This trade represents a 66.69 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the transaction, the executive vice president now directly owns 12,386 shares of the company's stock, valued at $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Analyst Ratings Changes

RYAN has been the subject of several analyst reports. UBS Group upped their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a "buy" rating in a research note on Tuesday, August 13th. JPMorgan Chase & Co. raised their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an "underweight" rating in a report on Friday, August 2nd. BMO Capital Markets upgraded shares of Ryan Specialty from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a "buy" rating in a research note on Thursday, October 10th. Finally, The Goldman Sachs Group increased their target price on Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a report on Wednesday, October 9th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $71.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.